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Abstract 
Translation, that is biosynthesis of polypeptides in accordance with information encoded in the 
genome, is one of the most important processes in the living cell and has been in the spotlight of 
international research for many years. The mechanisms of protein biosynthesis in bacteria and in the 
eukaryotic cytoplasm are now understood in great detail. However, much less is known about 
translation in eukaryotic mitochondria, which is characterized by a number of unusual features. In 
this review we summarize current knowledge about mitochondrial translation in different organisms 
while paying special attention to the aspects of this process that differ from cytoplasmic protein 
biosynthesis. 
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Introduction 
 
Almost all eukaryotic cells contain mitochondria. These organelles provide energy via the 
process of oxidative phosphorylation, and are involved in fatty acid, heme and iron-sulfur cluster 
biosynthesis, as well as programmed cell death. According to the generally accepted concept of 
endosymbiosis, mitochondria originated in the early stages of eukaryotic evolution from an 
endosymbiotic α-proteobacterium closely related to the modern Rickettsia prowazekii [1]. Over 
time, as a result of the tight association with the nuclear genome, many predecessors of 
mitochondrial genes have been transferred to the nucleus, but a small part of them are retained in 
the organelle DNA. Translation of mitochondrial messenger RNAs (mRNAs) in the mitochondrion 
is carried out by its own apparatus of protein biosynthesis, and requires fine coordination between 
the two genomes. 
Many aspects of mitochondrial translation remain poorly studied. This is largely due to the 
fact that mitochondrial translation systems capable of synthesis on natural matrices are still not 
reconstructed in vitro. On the basis of early studies of sedimentation characteristics and RNA 
composition of mitochondrial ribosomes, as well as their inhibition by antibiotics, it became 
apparent that mitochondrial translation is similar to that of bacteria [2 - 4]. Recently, it has become 
clear that the translation process in the mitochondria has a number of distinctive features [5, 6]. 
 A number of high resolution structural studies have aided our understanding of translation at 
the molecular level. The majority of these were performed on bacterial and eukaryotic cytosolic 
ribosomes [7]. However, considerable success has also been achieved in the study of structural and 
functional properties of the mitochondrial translational system. In this review we summarize the 
current understanding of protein synthesis in mitochondria. 
 
GENERAL FEATURES OF PROTEIN SYNTHESIS IN MITOCHONDRIA  
The mitochondrial genome, despite the universality of its function in energy generation 
shows a high degree of variation in composition, size and gene content across eukaryotes [8]. For 
example, the smallest mitochondrial genome described to date is the linear mitochondrial DNA 
(mtDNA) of Plasmodium falciparum (5,966 bp). This encodes, besides the large and small 
ribosomal RNA (rRNA), only three proteins [9]. The human circular mtDNA (16,569 bp) contains 
22 genes of transfer RNA (tRNA), 13 protein coding genes and 12S and 16S rRNA genes. 
Exceeding this by 22 times in size, the Arabidopsis thaliana mitochondrial genome (366,924 bp) 
contains information for only 32 proteins and an incomplete set of tRNAs [10, 11]. Such disparity is 
explained by an unusually large number (> 80%) of non-coding sequences in the mtDNA of A. 
thaliana compared with the Leishmania (<10%) and mammals, whose genes directly follow each 
other or are separated by only a few nucleotides [12]. The rate of evolution of the mitochondrial 
genome is extremely high, partly due to an increased frequency of mutations due to the lack of an 
effective repair system and its proximity to reactive forms of oxygen produced near the inner 
mitochondrial membrane [13]. 
An important feature of mitochondrial translation is a deviation from the standard genetic 
code. For example, in vertebrate mitochondria one of the three stop codons - UGA - corresponds to 
tryptophan, and AUA encodes methionine instead of isoleucine. Mitochondria often use alternative 
triplets as start codons: AUA (Homo, Bos), AUU (Homo, Mus), AUC (Mus) and GUG (Coturnix, 
Gallus). The amount of stop codons is reduced in mitochondrial systems: usually up to two, 
however 7 of 12 open reading frames of parasitic nematode Radopholis similis mitochondria are 
deprived of canonical stop codons [14]. Additionally, in yeasts Saccharomyces cerevisiae and 
Torulopsis glabrata codons starting with CU have been reassigned from leucine to threonine [15]. 
Transcription in almost all eukaryotic mitochondria is carried out by RNA polymerase 
homologous to that T3 and T7 phages [16]. The product of this synthesis is a polycistronic primary 
transcript [16 – 18]. According to the "tRNA punctuation" model, it is further processed by an 
endonucleolytic excision of tRNA sequences generating the individual protein-encoding mRNAs 
[19]. There are 11 human mitochondrial mRNAs: 9 monocistronic and two bicistronic with 
overlapping reading frames. In S. cerevisiae mitochondria there are 6 monocistronic mRNAs and 
one bicistronic mRNA coding for subunits 6 and 8 of F0F1-type ATP synthase [20]. Mitochondrial 
mRNAs lack the cap structure characteristic for the cytoplasmic translation, and are characterized 
by dramatic lineage-specific differences. Human mitochondrial mRNAs have very short 5'-and 3'-
untranslated regions (UTR), and are polyadenylated [20]. On the other hand, in Saccharomyces 
cerevisiae mature mitochondrial transcripts have long UTRs that are important for translation 
regulation, and are not polyadenylated [21 – 23]. Apparently, this reflects a fundamental difference 
in the mechanisms of recognition of the start codon and the initiator complex assembly in the 
mitochondria of yeast and mammals. Mitochondrial mRNAs, unlike those of bacteria, lack Shine-
Dalgarno sequences and, accordingly, the complementary segment of the small subunit rRNA. An 
octanucleotide sequence UAUAAAUA was suggested to play the role of a common ribosome 
recognition site in yeast but this hypothesis has not yet been experimentally confirmed [24]. The 
degradation of mitochondrial mRNA is controlled by a poly-subunit protein complex – 
degradosome possessing an RNA helicase, as well as hydrolytic or phospholytic exonuclease 
activities [25]. In yeast the mitochondrial polynucleotide phosphorylase was not detected, while in 
mammals, this enzyme was found in the intermembrane space, where, in addition to its main 
function, it participates in the regulation of RNA import into mitochondria [26]. 
The number of different tRNA species in mitochondria is usually significantly reduced in 
comparison to the cytoplasmic systems (22 and 24 in yeast and human, respectively), which is 
compensated by each of the tRNAs recognizing several codons. Mitochondrial tRNAs are usually 
shorter (59-75 nucleotides length in animals) than those of bacteria and the eukaryotic cytosol [27]. 
They often lack the conservative elements of the tertiary structure such as long-range interactions 
between D and T arms, and binding sites of magnesium cations, with the latter feature leading to 
their low thermal stability [28, 29]. Despite the absence of high resolution structural data, the results 
of chemical modification, nuclease protection and NMR spectroscopy of T7 transcripts of bovine 
and nematode mitochondrial tRNA suggest that they assume a structure similar to the canonical L-
form of the molecule [5]. This is confirmed by the results of cryoelectron microscopy of Bos taurus 
mitochondrial ribosomes: tRNA firmly bound in the peptidyl transferase center has a typical L-
conformation with a cavity in the "elbow" [30]. Despite the presence of a complete set of tRNAs in 
the mitochondrial genome of S. cerevisiae, one of the two cytoplasmic isoacceptor lysine tRNAs 
with CUU anticodon is also imported into the organelle and is involved in translation [31]. In 
contrast to animals and yeasts, the majority or even all types of mitochondrial tRNAs in plants and 
trypanosomatids are imported from the cytoplasm [32, 33]. 
Mitochondrial ribosomes (mitoribosomes) differ from 70S bacterial and 80S eukaryotic 
particles in several ways. Budding yeast mitoribosomes have a sedimentation coefficient of 74S, 
mammals - 55S, and Leishmania tarentolae - just 50S [34 – 36]. B. taurus and L. tarentolae 
mitoribosome structures resolved by cryoelectron microscopy to 9-14 Å are currently available [30, 
35]. As in all ribosomes, mitoribosomes have large and small subunits consisting of ribosomal RNA 
(rRNA) and proteins (see Table 1). The most significant difference between mitoribosomes and 
cytoplasmic analogues is in the RNA:protein ratio which is 2:1 in bacteria, while in B. taurus and L. 
tarentolae mitochondria - 1:2 and 1:3, respectively. At the same time mammalian mitoribosomes 
(2.71 MDa in mass and ~ 320 Å in diameter) are larger, but Leishmania mitoribosomes (2.2 MDa 
and ~ 245 Å) are smaller than the E. coli ribosome [30, 35]. Low values of sedimentation 
coefficients of mitoribosomes are due to their porous structure, which is a consequence of the 
absence or severe reduction of some segments of the rRNA [37]. For example, the small subunit 
12S rRNA is completely missing the anti-Shine-Dalgarno sequence as well as helices 6, 8-10, 12, 
13, 16, 17, 21, 33, 37 and 39-41 in the mammalian mitoribosome. Some of the lost elements are 
compensated for by new mitoribosome-specific proteins or by increased protein length relative to 
their bacterial counterparts. However, in mammals, only 19% of missing sequences in small subunit 
rRNA and 28% in large subunit rRNA are replaced with proteins, while a similar compensation in 
L. tarentolae mitoribosomes reaches 50%. This has led to a number of distinctive morphological 
features, while maintaining the general organization of the subunits. Such features include, for 
example, tunnel-like structures that link the intersubunit space with the external environment. 
Shielding of rRNA by proteins and the prevalence of protein-protein intersubunit bridges (9 of 15 in 
animals) are especially the case in mitoribosomes [30]. A unique feature of the small subunit of the 
mammalian mitoribosome is an extremely dynamic trihedral gate-shaped structure surrounding the 
mRNA entry site [30]. This is thought to help in attracting mRNAs lacking leader sequences to the 
small subunit. The large subunit is characterized by a massive central protuberance and a lack of 
electron density corresponding to 5S rRNA. However, biochemical studies have shown that 5S 
rRNA is imported into human mitochondria from the cytosol, and is associated with mitoribosomes 
[38, 39]. The absence of the core 16S rRNA elements constituting the classical E-site – helices 11 
and 68, and the loop portion lying between the helices 76 and 77, leads to very weak binding of 
tRNA to this region [40]. Another distinctive feature of the mitoribosomal large subunit is the 
presence of finger-like structures in the P-site, formed by the extension of a portion of the 
mitochondria-specific proteins of the central protuberance. This finger interacts with the T-loop of 
the tRNA molecule located in the P-site, and presumably exerts a stabilizing effect on the binding. 
Apparently, this is the reason that mitoribosomes, unlike bacterial ribosomes, are purified with 
tRNA firmly bound to the P-site. The organization of the tunnel through which the nascent peptide 
leaves the ribosome deserves special attention [41]. In the case of ribosomes of bacteria and 
eukaryotic cytoplasm, it leads to an opening referred to as Polypeptide Exit Site (PES). This is a flat 
structure, located in the lower part of the large subunit formed by elements of domains I and III of 
23S rRNA and ribosomal proteins L22, L23, L24 and L29. The situation is different in the case of 
L. tarentolae and B. taurus mitoribosomes, where one more hole was discovered at some distance 
from PES (~ 25 Å in the case of L. tarentolae), called PAS (Polypeptide-Accessible Site) [37, 42]. 
The formation of this structure results from the absence of most of domains I and III in the large 
subunit rRNA and its incomplete compensation by proteins. Thus, the exit of the nascent 
polypeptide chain from mitoribosome apparently can occur in two different ways.  
Mitochondrial ribosomes almost exclusively synthesize hydrophobic polypeptides that form 
the functional centers of electron transport chain complexes. In order to achieve efficient integration 
of nascent polypeptides into the inner mitochondrial membrane, translation and, most likely, 
assembly of the mitoribosomes occur directly on the membrane [43, 44]. The process of anchoring 
the mitoribosome on the mitochondrial membrane in S. cerevisiae is fairly well understood. It 
involves a number of proteins (Oxa1p, Mba1p, and Mdm38p) as well as mRNA molecules 
associated with the membrane through translational activators - a group of proteins involved in the 
organization and regulation of the translational machinery. Oxa1p interacts with the PES via the C-
terminal domain of the mitochondrial homolog of bacterial L23 [45, 46], Mba1p plays the role of 
mitoribosome receptor [47], and Mdm38p together with Mba1p bind the large subunit. Deletion of 
all genes encoding these proteins does not lead to complete dissociation of the ribosome from the 
membrane, indicating the existence of as yet undiscovered components involved in the process [48, 
49]. 
Several recent studies have described unexpected and intimate functional links between the 
mitochondrial translation and transcription. In human mitochondria, there is a free pool of the 
mitoribosomal large subunit protein MRPL12, which selectively binds to mitochondrial RNA 
polymerase in vivo and directly stimulates a transcription system in vitro [50]. This is considered to 
be one of the mechanisms coordinating the assembly of mitochondrial ribosomes. On the other 
hand, human mitochondrial RNA polymerase (POLRMT) has a role in mitoribosomal biogenesis 
and/or translation that is completely independent of its function in transcription. Co-
immunoprecipitation and fractionation of mitochondrial lysates indicate that POLRMT forms a 
complex with the 28S ribosomal subunit. This complex also includes a paralog of the mitochondrial 
transcription factor h-mtTFB2, protein h-mtTFB1, which acts as a 12S rRNA methyl transferase 
[51]. According to one hypothesis, by stimulating the methyl transferase activity of h-mtTFB1 and 
preventing the association of immature small subunits with 39S subunits, formation of the 
POLRMT•mitoribosome complex acts as a control point in the assembly path of the small subunit 
[51].   
Below we describe translation in mammalian mitochondria, with differences in the yeast 
system noted when necessary. 
 
Translation initiation in mitochondria 
COMMON FEATURES 
During the initiation of protein synthesis, scanning and positioning of the mRNA start codon 
occurs in the P-site of the small subunit. This is followed by binding of the initiator tRNA followed 
by association of the large subunit (subunit joining). Like all stages of translation, initiation is 
assisted by specific protein factors. There are three universal initiation factors bacteria, namely IF1, 
IF2 and IF3. In mitochondria, IF2mt is universally present and IF3mt has been identified in the vast 
majority of eukaryotes [52]. Both human factors have been characterized in detail in in vitro 
translation systems [53]. Using in vitro experiments with initiator complexes formed with 55S 
mitoribosomes from bovine liver on in vitro-synthesized 5'-terminal fragments of cytochrome 
oxidase subunit I (COI) and subunit II of NADH dehydrogenase (ND2) mRNAs in the presence of 
yeast mitochondrial initiator tRNA (fMet-tRNAi), the following model of mitochondrial translation 
initiation has been proposed (Fig. 1) [54]. First, IF3mt catalyzes the dissociation of 55S ribosomes, 
resulting in formation of free 39S subunits and 28S•IF3mt complexes. For convenience, binding of 
translational GTPase IF2mt•GTP is shown in the next stage, however the exact timing of its 
attachment to the complex is unknown. Next, mRNA is threaded through the unique gate-shaped 
structure in the 28S subunit, followed by the binding of fMet-tRNAi. This order of events is dictated 
by IF3mt, which, unlike its bacterial homologue, destabilizes initiator tRNA binding in the absence 
of mRNA [55]. Primer extension reaction inhibition assays have shown that upon initiation 
complex formation, the ribosome is stalled after first 17 nucleotides of mammalian mitochondrial 
mRNAs. From this it was postulated that the mitoribosome scans the 5'-UTR of mRNA in a search 
for the start codon, and when it is located in the P-site, translational GTPase IF2mt in a GTP-bound 
form promotes docking of fMet-tRNAi, with resultant codon-anticodon interactions stabilizing the 
initiation complex. If the interactions between the start codon and anticodon are not formed, the 28S 
subunit continues sliding along the mRNA and eventually dissociates. After initiator tRNA binding, 
the 39S subunit joins the complex, IF2mt hydrolyzes bound GTP to GDP, and the initiator factors 
leave the mature55S initiation complex, which is now ready for the elongation stage of polypeptide 
synthesis.  
The scheme of translation initiation described above is applicable only to mammalian 
mitochondria. Animal mitochondrial mRNAs lack long 5' UTRs (up to 3 nt in case of COI mRNA). 
The presence of only three additional nucleotides upstream of the start codon in COI mRNA 
reduces the efficiency of initiation complex formation by 40%, and 12 additional nucleotides at the 
5'-side of the AUG start codon lead to an 80% decrease [54]. A very different situation is observed 
in yeast, where the long 5'-UTRs precede the start codons, and interact with specific activators of 
translation (see below). Also in yeast mitochondria, unlike mammals, there are two methionine 
tRNAs: initiator and elongator. It was originally assumed that similarly to the bacterial case, 
formylation of methionine of the acylated initiator tRNA is strictly necessary for the initiation of 
translation. Surprisingly, it was shown that in S. cerevisiae translation initiation can occur in the 
absence of a formyl residue of fMet-tRNAi. An auxiliary factor Aep3p which promotes the binding 
of non-formylated tRNAi to IF2mt was discovered recently [56]. This protein is essential when only 
non-formylated initiator tRNA is available. Aep3p is a peripheral protein of the mitochondrial inner 
membrane and contains four RNA-binding PPR (penta-tricopeptide) motifs, and in addition to its 
role in translation initiation, it stabilizes the bicistronic mitochondrial mRNA encoding subunits 6 
and 8 of ATP synthase [57]. In mammals, the participation of a single methioninyl-tRNA in 
initiation or elongation is determined by competition between transformylase and elongation factor 
EF-Tumt: affinity of IF2mt to the formylated form is 50 times higher than to non-formylated, while 
EF-Tumt does not show detectable affinity to fMet-tRNAi [58]. 
The mitochondria of Saccharomyces fungi contain special translation activators, most of 
which are not found in mammalian mitochondria. In S. cerevisiae such specific protein factors are 
involved in translation of each of the eight polypeptides encoded in the mitochondrial genome [59]. 
Translational activators are encoded in the nuclear genome, and the proteins are transported to the 
mitochondrial inner membrane. Activators also coordinate the rate of synthesis of proteins encoded 
in the mitochondria with their subsequent assembly into the respiratory chain complexes. A detailed 
description of the translational activators can be found in a recent comprehensive review [60]. 
 
Mitochondrial translational initiation factors  
As was mentioned above, no mitochondrial ortholog of bacterial IF1 has been found in 
eukaryotes [61]. In bacteria this small protein (71 amino acid residues in E. coli) together with IF3 
is involved in fMet-tRNAi selection on the 30S subunit, blocking binding of the tRNA to the A site 
of the ribosome and inhibiting 50S subunit joining in the absence of fMet-tRNA. Until recently, it 
was thought that the absence of IF1 in mitochondria is generally compensated by a short insertion 
between domains V and VI (in accordance with the 6-domain scheme of IF2) in IF2mt [62]. This 
hypothesis is supported by the fact that the expression of bovine IF2mt allows E. coli cells to grow 
with a deletion of the gene encoding IF1 [62]. Cryoelectron microscopy reconstruction 70S 
ribosomes complexed with bovine IF2mt and fMet-tRNAi in the presence of mRNA and non-
hydrolyzable analogue of GTP, GDPNP, suggested that the insertion in IF2mt occupies the same 
area on the intersubunit surface of the 30S particle as IF1 in a bacterial system [61]. However, 
bioinformatic analysis showed that this amino acid sequence is only conserved in vertebrates [52]. 
Therefore, it appears that this phenomenon is not universal and the insertion has evolved 
secondarily to the loss of IF1mt.  
IF2mt is a highly conserved protein, homologous to IF2 of bacteria and archaea, and to the 
corresponding eukaryotic cytosolic factor eIF5B. By analogy with the 6-domain organization of IF2 
in E. coli, 4 domains are identified in IF2mt: III, IV, V and VI; the latter is composed of two 
subdomains (CI and CII) [63]. Domain IV is a classic G-domain - the binding site of guanidinyl 
nucleotides [53]. In the presence of GDPNP, IF2mt binds to the 28S subunit 3 times more efficiently 
than in the presence of GDP, and 10 times more efficiently than in the absence of nucleotides, 
whereas the dissociation constant for the complex of 28S•IF2mt, measured in experiments with 
biotinylated mitoribosomes in the presence of GDPNP, was found to be 10-20 nM [64]. Domain III 
forms contacts with the mitoribosome small subunit and the VICII domain is involved in binding of 
the CCA-end of fMet-tRNAi. The animal-specific insertion between domains V and VICI, that was 
suggested to play the role of a lost homolog of IF1, contacts helices h18 and h44 of rRNA and the 
protein S12. 
The situation with the third mitochondrial translation initiation factor IF3mt is much more 
complicated. The low degree of homology with the bacterial factor (the human factor shares 20.8% 
identity with IF3 of E. coli) was for a long time an obstacle to detection of the respective factor in 
the mitochondria of eukaryotes. An initial search for IF3mt orthologs in the Homo sapiens EST 
database using E. coli IF3 as the query was not successful [65]. However, candidate genes were 
successfully identified both in human and mouse using Mycoplasma sp. and Euglena gracilis 
chloroplast IF3s as queries [65]. Candidates for the role of this factor in the genomes of 
invertebrates and lower eukaryotes have proved harder to find. By using a sensitive PSI-Blast 
algorithm, an IF3mt ortholog in yeast S. cerevisiae - Aim23p, was found [52]. The growth of yeast 
cells with the AIM23 gene deletion on a medium with non-fermentable carbon sources was restored 
in the presence of the gene encoding S. pombe IF3mt, which fully confirms the in silico results. The 
mammalian IF3mt is 278 amino acid residues long, and comprises two domains connected by a 
linker, as does its bacterial ortholog. According to computer modeling, the N-terminal domain of 
IF3mt (hereinafter N-domain) is composed of α-helical region located opposite a β-layer composed 
of 4 chains and a second α-helix joining the linker region [66]. The C-terminal domain (hereinafter 
C-domain) contains two α-helices (H3 and H4) lying on the β-layer consisting of four chains. One 
of the chains is divided into two segments by a proline residue. IF3mt has N-and C-terminal "tails", 
31 and 33 amino acid residues long, respectively. It also has an N-terminal signal peptide that 
directs import into the mitochondrion and is cleaved to give the mature form upon the protein 
reaching the matrix. Both tail segments can not be modeled on the basis of currently available 
structural data, and presumably acquire a certain conformation only upon binding to the small 
subunit of the mitoribosome. The linker region is partially α-helical, and biochemical studies of the 
bacterial homologue indicate that the linker is highly flexible [67].  
As is the case with the bacterial factor, IF3mt promotes the assembly of the initiator complex 
on the 28S subunit if the system contains mRNA and IF2mt•GTP. This is achieved through 
dissociation of active 55S ribosomes to large and small subunits [65]. Unlike its bacterial 
counterpart, IF3mt does not promote dissociation of non-cognate initiation complexes and the 
residues critical for this activity are not conserved in the mitochondrial factor [55]. 
There are functional differences between the N-and C-domains of bacterial and 
mitochondrial factors. In the case of the bacterial protein the N-domain serves as an additional 
anchoring point for binding to the ribosome, while the functional activities reside in the C-domain. 
The two domains are connected by the linker region. The roles of the individual domains of IF3mt in 
the factor’s interactions with the ribosome were elucidated through a series of mutational 
experiments [66]. The C-domain plus linker region combined has the greatest affinity to the small 
subunit (Kd of 60 nM vs. 30 nM for the full-length protein). The binding of the N-domain to the 
28S subunit is characterized by a larger Kd value of 240 nM. Removal of the linker leads to a 
decrease in affinity (Kd is 90 and 390 nM, in the case of the full-length protein and N-domain, 
respectively). Therefore, it was proposed that the linker region modulates IF3mt-mediated 
dissociation of the ribosome into subunits. Replacements of C-terminal domain amino acid residues 
at positions 170, 171 and 175 to alanine lead to a virtually complete loss of the factor’s activity in  
dissociation of the mitoribosome and stimulation of the initiation complex formation, while having 
little effect the protein’s affinity to the small subunit. Most likely, these residues play an important 
role in blocking the intersubunit bridge B2b.  
The roles of N- and C-terminal ‘tails’ in the IF3mt functional cycle was analyzed in another 
series of mutational experiments [68]. Surprisingly, removal of these regions leads to a tenfold 
increase in the affinity of the factor to the large subunit, with the majority of this effect determined 
by the N-terminal extension. As was mentioned in the previous section, IF3mt has another property 
which differs from its bacterial homologues, namely dissociation of fMet-tRNAi from the complex 
with the 28S subunit in the absence of mRNA. This activity requires the presence of the C-terminal 
‘tail’ and the linker region, with the amino acid residues at positions 247 and 248 playing a key 
role. According to the available three-dimensional model, the C-terminal extension is directed 
toward the linker region, which allows these sections of the protein to act together.  
There are considerable differences between the IF3 and the IF3mt binding sites on the small 
subunit, as was determined using chemical cross-linking followed by mass spectrometry [69]. The 
full-length IF3mt binds to ribosomal proteins MRPS5, MRPS9, MRPS10, MRPS18, which have 
corresponding homologs in the 70S ribosome, as well as with a group of mitochondria-specific 
proteins of the small subunit: MRPS29, MRPS32, MRPS36 and PTCD3. The only ribosomal 
protein cross-linked to the N-domain of IF3mt is MRPS10, located in the head of 28S subunit, with 
the rest of the detected proteins being cross-linked to the C-domain and linker. 
 
Translation elongation in mitochondria 
General features 
Comparison among all known translation systems shows that the elongation stage of 
translation has been particularly well conserved during evolution. The mitochondrial elongation 
factor GTPase EF-Tumt (Elongation Factor Thermounstable) forms a ternary complex with GTP and 
aminoacyl-tRNA, and delivers the latter to the A-site of mitoribosome [70]. Formation of the 
cognate codon-anticodon interaction promotes GTP hydrolysis by EF-Tu leading to the release of 
the factor from the ribosome. The guanine nucleotide exchange factor EF-Tsmt (Elongation Factor 
Thermostable) promotes replacement of GDP with GTP on EF-Tumt. Next, the ribosome catalyzes 
the transpeptidation reaction. This results in a pre-translocation complex with the P-site occupied by 
the deacylated tRNA and the A-site harboring the peptidyl-tRNA that has been extended by one 
amino acid residue. In the final step of elongation, the mitochondrial GTPase EF-G1 (Elongation 
Factor G 1) catalyzes the movement of mRNA by one codon in the 5'-3' direction, resulting in 
deacylated tRNA leaving the ribosome, and the peptidyl-tRNA moving in the P-site, completing the 
cycle. The E (Exit) site that transiently binds the deacylated tRNA dissociating from the ribosome is 
universal for bacterial and eukaryotic cytosolic ribosomes. However, its existence is still being 
questioned in the case of the mitochondrial ribosomes [30].  
 
Mitochondrial translation elongation factors  
EF-Tumt is extracted from the mitochondrial fraction of bovine liver in a tight complex with 
EF-Tsmt (Elongation Factor Thermostable) and remains associated in the presence of GDP 
concentrations up to 1 mM [71]. This is due to the balance of EF-Tumt affinities to G nucleotides 
and EF-Tsmt: the Kds for binding of GTP and GDP are 1 and 18 mM, respectively, while binding to 
EF-Tsmt is considerably tighter with Kd of 5.5 nM [72]. Both factors are present in mitochondria in 
vivo in a stoichiometric ratio of 1:1, with around 400 copies per mitochondrion. This is different 
from the pattern in bacteria, where the ratio is 8:1 and ≈ 200,000 molecules, respectively [73]. A 
mitochondrial localization signal was determined for both proteins by sequencing the N-terminus in 
purified preparations of isolated mitochondria [74].  
X-ray crystallography of EF-Tumt•GDP complex shows a three-domain organization 
scheme, typical of bacterial homologs [75]. Domain I consists of 8 α-helices and 8 β-strands that 
form the binding pocket for guanyl nucleotides. A flexible linker of 11 amino acid residues joins the 
G-domain with domain II, which is formed by 11 β-strands folded in a "Greek key" motif. Domain 
III folds into a “jellyroll” structure, formed by a β-layer of 6 sheets. A unique feature of 
mitochondrial EF-Tu is the presence of a C-terminal extension. In humans and Bos taurus, its 
length is 11, and in C. elegans - 57 amino acid residues. It is thought that this extension in 
nematodes is required for the formation of the ternary complex with tRNAs, which typically have 
unusually short T-stems and a complete absence of the D-stem in these organisms. However, the 
function of the extension in mammals is associated with the binding of aminoacyl-tRNA to the 
small ribosomal subunit [75].   
The binding pocket for the acceptor arm of aminoacyl-tRNA is formed at the junction 
between domains I and II / III of EF-Tumt. Interestingly, the mitochondrial factor is active in a 
system with bacterial tRNAs, while EF-Tu from E. coli is not able to participate in elongation using 
mitochondrial tRNAs [76, 77]. The formation of a correct codon-anticodon duplex in the A site 
sends a signal through the tRNA molecule to the G-domain of EF-Tu that leads to hydrolysis of 
GTP [78]. Presumably, the shorter mitochondrial tRNA molecules in complex with bacterial EF-Tu 
are not correctly positioned on the ribosome and can not effectively stimulate nucleotide hydrolysis. 
In addition to participating in translation elongation, EF-Tumt acts as a chaperone in the 
process of quality control of mitochondrial proteins [79]. EF-Tumt binds to unfolded or misfolded 
newly synthesized polypeptides and directs them to the protease complex, where they are degraded.  
The low degree of sequence similarity of EF-Tsmt with its bacterial homologs (25-35%) has 
prevented reliable predictions from being made about its three-dimensional structure. Bacterial EF-
Ts consists of four domains: the N-terminal, a core domain (divided by N- and C-subdomains), a 
dimerization domain with a «coiled-coil» fold, and a C-terminal module [80]. The X-ray structure 
of the EF-Tumt•EF-Tsmt complex has revealed dramatic differences from the organization outlined 
above [81]. The most conserved part of the protein - the N-domain -is assembled from three α-
helices similarly to the bacterial homolog. The core domains of the two proteins share the "β-
sandwich" fold, although the number the organization of the β-strands varies. The most dramatic 
difference between the two proteins is a reduction of the dimerization domain to  large loop folded 
opposite to the C-subdomain and the complete absence of the C-terminal module in the 
mitochondrial counterpart [81]. 
Interactions between EF-Tsmt and EF-Tumt•GDP lead to large-scale conformational changes 
in the latter, which is not the case for the corresponding E. coli and T. thermophilus complexes. 
GDP to GTP exchange is accompanied by significant conformational rearrangements in EF-Tumt 
leading to the disruption of the G-nucleotide binding site, which presumably occurs in three steps 
[82 – 84]. First, the Mg2+ ion binding site is disrupted, followed by the destabilization of EF-Tumt 
interactions with the oxygen atoms of the GDP β-phosphate moiety, and, lastly, contacts with the 
ribose and purine ring are lost.  
The equivalent of bacterial EF-Ts is absent in budding yeast S. cerevisiae, however, is found 
in fission yeast Schizosaccharomyces pombe. In this respect at least, the fission yeast mitochondrial 
system is more similar to that of humans than is budding yeast. EF-Tumt in S. cerevisiae as 
profoundly different affinities to for GTP and GDP in comparison to that of E. coli EF-Tu (5 and 25 
μM vs 300 and 3 nM, respectively) and, therefore, does not require stabilization by GDP [85]. The 
functional link between the absence of EF-Tsmt and low affinities to G nucleotides of S. cerevisiae 
EF-Tumt was demonstrated by mutational analysis [86]. Single point mutations in S. pombe EF-Tumt 
lowering its affinities to G nucleotides also lead to its independence from the EF-Tsmt rendering S. 
pombe EF-Tumt functionally similar to its S. cerevisiae counterpart. 
EF-G catalyses the translocation of peptidyl-tRNA from the A- to the P-site of the ribosome. 
In contrast to bacteria in which a single EF-G acts both during elongation and ribosomal recycling, 
in most eukaryotes the two functions are split between two mitochondrial factors, EF-G1mt and EF-
G2mt [87, 88]. These two factors have amino acid sequence identity of 35% in average [87]. EF-
G1mt has translocation activity with both 55S mitoribosomes and 70S bacterial monosomes. 
Bacterial EF-G, however, is incompatible with mitochondrial ribosomes. Experiments on hybrid 
ribosomes with heterologous ribosomal proteins L7/L12 demonstrated that the specificity lies in the 
interactions with these proteins [89].  
Despite the fact that EF-G1mt was isolated from bovine liver many years ago, it is still one of 
the most poorly characterized proteins of the mitochondrial translation apparatus [90]. As with the 
bacterial protein, EF-G1mt can be structurally divided into 5 domains, and its shape is strikingly 
similar to that of the ternary complex EF-Tu•GDPNP•Phe-tRNAPhe [91]. Despite the fact that the 
amino acid residues involved in EF-G’s interaction with antibiotic fusidic acid are present in the 
mitochondrial factor, the antibiotic does not significantly inhibit EF-G1mt both in the presence of 
bacterial and mitochondrial ribosomes [90].  
 
Translation termination and recycling in the mitochondria  
The third and fourth stages of protein synthesis in mitochondria occur when the stop codon 
of mRNA is present in the ribosomal A-site and is decoded by a termination, or Release Factor, RF. 
The stop codon is recognized by RF1amt (Release Factor 1), which promotes hydrolysis of the ester 
bond between P-site tRNA and the newly synthesized polypeptide, releasing the completed protein 
[92]. The cleavage occurs in the peptidyl transferase center of the large subunit. The mechanism of 
RF1amt release from its complex with mitoribosomes is still unknown. Next, two factors – RRF1mt 
(Ribosome Recycling Factor) and EF-G2mt in complex with GTP – jointly promote the dissociation 
of tRNA and mRNA from the ribosome and split the ribosomal particles into subunits (Fig. 3), 
setting the stage for the re-use of the ribosome in the next round of translation. GTP hydrolysis by 
EF-G2mt is required for the release of RRF1mt and EF-G2mt from the ribosome [92]. 
Until recently, it was widely believed that human mitochondria have an extended repertoire 
of termination codons in comparison with the bacterial system [93]. Two open reading frames are 
terminated by non-standard triplets: AGA and AGG in genes MTCOI and MTND6, respectively. 
However, recent investigations suggest that the 55S mitoribosome undergoes a -1 frameshift, which 
results in a standard UAG stop codon that is recognized by RF1mt in the A site [94].  
There are two classes of termination factors in bacteria, archaea and the eukaryotic cytosol: 
class-I and class-II [95]. The class-I factors are involved in direct recognition of the stop codon and 
release of the peptide, whereas class-II factors facilitate the release of the class-I factors from the 
ribosome. Class-II factors have not been found in mitochondria. In archaea and in the cytoplasm of 
eukaryotes all three stop codons are recognized by a single class-I release factor – aRF1 and eRF1, 
respectively; and in bacteria – by two proteins, RF1 and RF2. The UAA codon is recognized by 
both bacterial factors; RF1 specifically recognizes UAG, and RF2 – UGA [96, 97]. Bioinformatic 
analyses have showed that the mitochondrial factors have greatest sequence similarity to the 
bacterial RF1 [98].  
The three-dimensional structure of human RF1mt has been modeled using the available 
structure of Thermus thermophilus RF1 [92]. It was found that all protein domains and motifs 
typical for this class are present in the mitochondrial factor: the PXT motif of domain 2 (PKT in the 
case of the mitochondrial factor) participating in stop codon recognition, the 5 α-helix tip of domain 
4, as well as the highly conserved GGQ motif of domain 3 that catalyzes the hydrolysis of an ester 
bond between the tRNA and the newly synthesized peptide [99]. Moreover, the arrangement of 
functional sites is compatible with the "open" conformation of the factor that is required for its 
functional activity on the ribosome [100]. Two additional proteins possessing the RF-specific GGQ 
motif are present in human mitochondria in addition to RF1mt, namely ICT1 and C12 [101, 102]. 
ICT1 has ribosome-dependent, A-site-codon-independent peptidyl hydrolase activity. This protein 
is thought to promote the release of peptides from ribosomes "stuck" on mRNAs lacking a stop 
codon, thus performing a function analogous to tmRNA in bacteria [103]. Co-immunoprecipitation 
experiments show that ICT1 is tightly associated with mitoribosomal large subunits, and 
functionally active in a heterologous system with bacterial 70S ribosomes.  
As mentioned in the previous chapter, there are two forms of the protein EF-G, EF-G1mt and 
EF-G2mt, in the mitochondria of most eukaryotes. The former appears to be responsible for 
translocation, whereas the latter is involved in ribosomal recycling. This view is supported by 
recent in vivo results using an E. coli strain carrying a temperature-sensitive RRF variant. In this 
strain, EF-G2mt in combination with RRFmt is able to restore normal growth at non-permissive 
temperatures [103]. Molecular phylogenetic analysis of the EF-G protein family suggests an 
asymmetric separation of functional activities between the two EF-Gs: EF-G2mt is highly divergent, 
primarily conserving sites that maintain an EF-G–like architecture and ribosome-binding 
capabilities, while EF-G1mt has experienced substantial and well conserved changes in the G-
domain that suggest a modified mechanism of interaction with nucleotides [104]. 
The ribosomal recycling stage in mitochondria differs from the bacterial system in another 
important aspect: GTP hydrolysis by EF-G2mt appears to occur after mitoribosome dissociation into 
subunits and is required for dissociation of EF-G2mt and RRFmt from the large subunit, allowing the 
subunits to associate again in the absence of IF3mt [103]. 
 
Conclusions and perspectives  
In this review we have attempted to compile the available data on protein synthesis in the 
mitochondria of eukaryotic cells. Our current knowledge of protein synthesis in mitochondria is still 
rather limited in comparison to that of bacterial and cytosolic translation in eukaryotes. Atomic 
resolution structures of the mitochondrial ribosome are lacking, and our biochemical understanding 
of the mitochondrial translation lacks kinetic details. Although mitochondrial translation is 
generally organized similarly to that in bacteria it is characterized by a number of significant 
differences. In recent years numerous scientific reports have elucidated these differences, reigniting 
the interest of the scientific community. 
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Bacteria Bovine mitochondria 
Leishmania 
mitochondria 
Molecular weight, 
MDa 
2.3 2.7 2.2 
Diameter, Å ≈ 260 ≈ 320 ≈ 245 
Molar ratio 
RNA:protein 
≈ 2:1 ≈ 1:2 ≈ 1:3 
Small subunit rRNA 
and its size 
16S  (1542 nt) 12S (950 nt) 9S (610 nt) 
Number of proteins in 
small subunit 
21 ≈ 29 ≈ 56 
Large subunit rRNA 
and its size 
23S rRNA (2904 nt) 
5SrRNA (120 nt) 
16SrRNA 
(1560 nt) 
12S rRNA 
(1173 nt) 
Number of proteins in 
large subunit 
34 ≈ 50 ≈ 77 
 
Table 1. General features of mitochondrial and bacterial ribosomes. 
 
Figure 1. Schematic representation of translation initiation in mitochondria.SRS – small 
ribosome subunit, LRS – large ribosomal subunit. See text for detailed information. 
 
Figure 2. Schematic representation of translation elongation in mitochondria.SRS – small 
ribosome subunit, LRS – large ribosomal subunit. See text for detailed information. 
 
Figure 3. Schematic representation of translation termination in mitochondria.SRS – small ribosome 
subunit, LRS – large ribosomal subunit. See text for detailed information. 
 
 
 
 
 
SRS
LRS
mtRNA
GDP
GTP
fmet-tRNAi
IF3mt
IF2mt
АP
АP
mtRNA
GDP
GTP
EF-G1mt
EF-Tumt
EF-Tsmt
tRNA
SRS
LRS
peptide
А А А А
А
P P P P
P
P
SRS
LRS
mtRNA
GDP
GTP
RF1amt
RRF1amt
EF-G2mt
tRNA
peptide
АP АP АP
АP
